Geode Capital Management LLC Has $88.24 Million Position in Cabot Corporation $CBT

Geode Capital Management LLC trimmed its stake in shares of Cabot Corporation (NYSE:CBT) by 0.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,331,061 shares of the specialty chemicals company’s stock after selling 8,982 shares during the quarter. Geode Capital Management LLC owned approximately 2.55% of Cabot worth $88,237,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Smartleaf Asset Management LLC increased its position in Cabot by 598.0% during the 3rd quarter. Smartleaf Asset Management LLC now owns 349 shares of the specialty chemicals company’s stock worth $27,000 after purchasing an additional 299 shares in the last quarter. Torren Management LLC acquired a new position in Cabot during the 4th quarter worth approximately $26,000. Hantz Financial Services Inc. increased its position in Cabot by 227.5% during the 3rd quarter. Hantz Financial Services Inc. now owns 429 shares of the specialty chemicals company’s stock worth $33,000 after purchasing an additional 298 shares in the last quarter. Geneos Wealth Management Inc. increased its position in Cabot by 409.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 364 shares in the last quarter. Finally, Global Retirement Partners LLC increased its position in Cabot by 1,606.9% during the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock worth $33,000 after purchasing an additional 466 shares in the last quarter. 93.18% of the stock is currently owned by institutional investors and hedge funds.

Cabot Trading Down 0.0%

Shares of NYSE CBT opened at $80.86 on Monday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.96 and a current ratio of 1.45. Cabot Corporation has a 52-week low of $58.33 and a 52-week high of $89.46. The firm has a 50 day moving average price of $79.11 and a two-hundred day moving average price of $73.09. The stock has a market cap of $4.17 billion, a P/E ratio of 15.28, a price-to-earnings-growth ratio of 10.67 and a beta of 0.82.

Cabot (NYSE:CBT) last announced its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.47 by $0.14. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The firm had revenue of $904.00 million during the quarter, compared to analysts’ expectations of $900.31 million. During the same period in the prior year, the company posted $1.90 EPS. The company’s revenue was down 3.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. As a group, equities analysts forecast that Cabot Corporation will post 6.32 EPS for the current year.

Cabot Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Friday, May 29th will be given a $0.4725 dividend. This is an increase from Cabot’s previous quarterly dividend of $0.45. The ex-dividend date is Friday, May 29th. This represents a $1.89 annualized dividend and a yield of 2.3%. Cabot’s dividend payout ratio is currently 35.73%.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on CBT shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research report on Tuesday, May 26th. JPMorgan Chase & Co. upped their price objective on shares of Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a research report on Wednesday, May 13th. UBS Group upped their price objective on Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a research note on Friday, May 8th. Mizuho raised their price objective on shares of Cabot from $75.00 to $80.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. Finally, Wall Street Zen lowered shares of Cabot from a “buy” rating to a “hold” rating in a report on Saturday. One investment analyst has rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Cabot presently has a consensus rating of “Hold” and an average target price of $80.25.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.